Captopril Tablets — Class II drug recall D-1109-2015
Terminated recall by Blenheim Pharmacal, Inc., reported 2015-06-03, distributed in IN. cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limit
| Recall number | D-1109-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Blenheim Pharmacal, Inc., North Blenheim, NY, United States |
| Recall initiated | 2015-05-22 |
| Classified | 2015-05-28 |
| Reported by FDA | 2015-06-03 |
| Terminated | 2016-01-15 |
| Distributed | IN |
| Quantity | 166 bottles |
| Reason classes | cgmp |
| NDC | 10544-0175-30, 64679-0904-02 |
| Lot numbers | BP20101301 |
| Expiration dates | 2016-02-28 |
Product
Captopril Tablets, USP, 50 mg, 30 Tablets, Rx Only, Dist. By: Wockhardt USA LLC, Parsippany, NJ 07054, Packaged By: Blenheim Pharmacal Inc. North Blenheim, NY 12131, NDC 10544-175-30, MFG: 64679-904-02
Reason for recall
cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1109-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.